Strides Pharma Science Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science has informed the exchanges that its trading window will be closed from October 1, 2025, until 48 hours after the company declares its financial results for the quarter and half year ending September 30, 2025. This is a standard compliance measure under SEBI's Prohibition of Insider Trading Regulations, 2015, restricting insiders from trading in the company's shares during a sensitive period. The date of the board meeting to announce the Q2/H1 FY26 results will be communicated separately. The filing has been signed by the Company Secretary & Compliance Officer.
No direct impact on shareholders. This is a routine regulatory filing and does not affect the company's business or stock price. Insiders (directors, officers, and designated employees) cannot trade in the stock until 48 hours after results are announced, which is normal practice ahead of earnings.